NCT05830253Completed
Free-living Monitoring of Parkinson's Disease Using Smart Objects
Free-living Monitoring of Parkinson's Disease Using Smart Objects: Towards Digital Medicine
Source: ClinicalTrials.gov · Last updated 20 Feb 2025
Brief summary (registry, in English)
Parkinson's disease, one of the most common neurodegenerative diseases of the central nervous system, presents motor symptoms, including tremor, rigidity, bradykinesia, and postural instability. Assessments of patients with Parkinson's disease are typically performed using clinical scales, compiled by the healthcare staff or by the patient. Although commonly used in clinical practice, they have some limitations, including the low temporal resolution of the scales, the low granularity of the scores and the possible low inter- and intra-operator reliability. The recent development of digital technologies has led to the creation of IoT (Internet of Things) devices capable of providing quantitative indicators, potentially useful for an accurate differential diagnosis, as well as for monitoring the effects of therapeutic interventions. The peculiarity of these systems is the ability to provide indicators not only during periodic visits to the clinic, but also the ability to remotely monitor the patient's daily life activities. In this scenario, this study wants to test the hypothesis that the IoT devices like smart-ink pens and insoles are usable options for monitoring patients with Parkinson's disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 8 Mar 2023
- Start date
- 8 Sept 2021
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Diseases
- Parkinson disease
- NCT number
- NCT05830253
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 8 Sept 2021 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of major neurological, vascular, musculoskeletal disorders
Other illness
- Unstable pharmacological treatment for Parkinson's Disease during the study
Who the study is looking for
- Adult individuls
- Cognitive impairments
- Ability to independently sign the written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituti Clinici Scientifici Maugeri Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.